FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for tacrolimus from Sandoz Inc., updating labeling related to its use in preventing organ transplant rejection. The supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)